Cathay Biotech (SH:688065) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-08-01 23:13Group 1 - The company will hold its second extraordinary general meeting of shareholders in 2025 on August 18 at 14:00 in Shanghai [2][4] - The voting will be conducted through both on-site and online methods, with specific time slots for each [4][6] - Shareholders must register to attend the meeting, with detailed requirements for both individual and corporate shareholders [10][12] Group 2 - The meeting will review several proposals, including the election of the third board of directors, which will consist of 5 non-independent directors, 3 independent directors, and 1 employee representative director [24][26] - The election will utilize a cumulative voting system, allowing shareholders to allocate their votes among candidates [9][22] - The current board will continue to operate until the new board is elected [27] Group 3 - The company has initiated a share repurchase program, with a total budget between RMB 10 million and RMB 20 million, and a maximum repurchase price of RMB 67 per share [38][39] - As of July 31, 2025, the company has repurchased 230,366 shares, representing 0.0319% of the total share capital, at a total cost of approximately RMB 10.5 million [40] Group 4 - The company has decided to abolish its supervisory board, transferring its responsibilities to the audit committee of the board of directors [43] - Amendments to the company's articles of association and related internal management systems will be made accordingly [45]